Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 22677 matches for

Novartis receives European licence for Aimovig® (erenumab), the first treatment designed specifically for the prevention of migraine

Human pain nerves grown in the lab that can release CGRP and be used to identify new migraine treatments

Similar stories

Making your lab more sustainable – top tips for LEAF accreditation

Need inspiration on how to start working towards your lab ‘LEAF’ accreditation? We spoke to DPhil students Sylvia Franklin and Molly John from the MacLaren and Xue Labs respectively, who led a recent lab clear-up which has helped them save resources and avoid waste.

MRC iCASE Award for Oxford-Elasmogen research partnership

In Conversation: Professor Kevin Talbot and Professor Arjune Sen

Dr Bjorn Vahsen wins Junior Research Prize

Research about whiplash published in two new papers

Vice-Chancellor’s Awards nominations in NDCN